@jmab You got it exactly about not accepting "one-size-fits all!
Thanks for sharing about the 5-day radiation therapy clinical results from ENGLAND. It figures that US companies were after the profits.
I believe that is why there's no funding for breast cancer clinical studies looking at lower doses of AIs...just not profitable and is in conflict with selling more drugs. When I told my Oncology Nurse Practitioner that I was taking Exemestane 3X/week, she dismissed it as ineffective. I didn't bother to share that Dr. Andrea De Censi, oncologist from Italy, who has done the research, recommends taking every other day if one has side effects. Europe and the UK seem to be more progressive than US here.